Evidence map›Paper›PMID 27382523›Full record

ReviewCureus2016

Hypertonicity: Pathophysiologic Concept and Experimental Studies.

Christos Argyropoulos, Helbert Rondon-Berrios, Dominic S Raj, Deepak Malhotra, Emmanuel I Agaba, Mark Rohrscheib, Zeid Khitan, Glen H Murata, Joseph I Shapiro, Antonios H Tzamaloukas

Open access · diamondAbstract readReview
In one paragraph

Review in Cureus, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Dialysis-associated hyperglycemia: manifestations and treatment.International urology and nephrology · 2020
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Christos ArgyropoulosDepartment of Medicine, Division of Nephrology, University of New Mexico School of Medicine.
Helbert Rondon-BerriosDepartment of Medicine, Renal-Electrolyte Division, University of Pittsburgh Medical School.
Dominic S RajGeorge Washington University.
Deepak MalhotraUniversity of Toledo.
Emmanuel I AgabaDepartment of Medicine, Jos University Teaching Hospital, Jos, Plateau State, Nigeria.
Mark RohrscheibDepartment of Medicine, Division of Nephrology, University of New Mexico School of Medicine.
Zeid KhitanDepartment of Medicine, Division of Nephrology, University of New Mexico School of Medicine.
Glen H MurataRaymond G. Murphy VA Medical Center, Albuquerque, New Mexico.
Joseph I ShapiroThe Joan C Edwards College of Medicine of Marshall University, Huntington, WV.
Antonios H TzamaloukasUniversity of New Mexico School of Medicine.
George Washington University · USRaymond G. Murphy VA Medical Center · USMarshall University · USJos University Teaching Hospital · NGRenal Association · GB

Funding

CORAL: Clinical Coordinating CenterU01HL071556 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI COOPER, CHRISTOPHER J · 2004 to 2013
$19.3M
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac DiseasesR01HL109015 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SHAPIRO, JOSEPH ISAAC, XIE, ZIJIAN · 2011 to 2014
$2.2M
NHLBI NIH HHS R01 HL109015NHLBI NIH HHS U01 HL071556
6 · The paper itself

Abstract

Disturbances in tonicity (effective osmolarity) are the major clinical disorders affecting cell volume. Cell shrinking secondary to hypertonicity causes severe clinical manifestations and even death. Quantitative management of hypertonic disorders is based on formulas computing the volume of hypotonic fluids required to correct a given level of hypertonicity. These formulas have limitations. The major limitation of the predictive formulas is that they represent closed system calculations and have been tested in anuric animals. Consequently, the formulas do not account for ongoing fluid losses during development or treatment of the hypertonic disorders. In addition, early comparisons of serum osmolality changes predicted by these formulas and observed in animals infused with hypertonic solutions clearly demonstrated that hypertonicity creates new intracellular solutes causing rises in serum osmolality higher than those predicted by the formulas. The mechanisms and types of intracellular solutes generated by hypertonicity and the effects of the solutes have been studied extensively in recent times. The solutes accumulated intracellularly in hypertonic states have potentially major adverse effects on the outcomes of treatment of these states. When hypertonicity was produced by the infusion of hypertonic sodium chloride solutions, the predicted and observed changes in serum sodium concentration were equal. This finding justifies the use of the predictive formulas in the management of hypernatremic states.

Indexed as

hypertonicityosmolalityosmolarityosmolytesserum sodium concentration

Identifiers

PMID27382523
PMCPMC4895078
OpenAlexW2345488178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.